Dravet Syndrome (DS) is caused by heterozygous loss-of-function mutations in voltage-gated sodium channel Na V 1.1. Our mouse genetic model of DS recapitulates its severe seizures and premature death. Sleep disturbance is common in DS, but its mechanism is unknown. Electroencephalographic studies revealed abnormal sleep in DS mice, including reduced delta wave power, reduced sleep spindles, increased brief wakes, and numerous interictal spikes in Non-Rapid-Eye-Movement sleep. Theta power was reduced in Rapid-Eye-Movement sleep. Mice with Na V 1.1 deleted specifically in forebrain interneurons exhibited similar sleep pathology to DS mice, but without changes in circadian rhythm. Sleep architecture depends on oscillatory activity in the thalamocortical network generated by excitatory neurons in the ventrobasal nucleus (VBN) of the thalamus and inhibitory GABAergic neurons in the reticular nucleus of the thalamus (RNT). Whole-cell Na V current was reduced in GABAergic RNT neurons but not in VBN neurons. Rebound firing of action potentials following hyperpolarization, the signature firing pattern of RNT neurons during sleep, was also reduced. These results demonstrate imbalance of excitatory vs. inhibitory neurons in this circuit. As predicted from this functional impairment, we found substantial deficit in homeostatic rebound of slow wave activity following sleep deprivation. Although sleep disorders in epilepsies have been attributed to anti-epileptic drugs, our results show that sleep disorder in DS mice arises from loss of Na V 1.1 channels in forebrain GABAergic interneurons without drug treatment. Impairment of Na V currents and excitability of GABAergic RNT neurons are correlated with impaired sleep quality and homeostasis in these mice.
Introduction
Dravet Syndrome (DS) is a debilitating, drug-resistant, and lifethreatening childhood-onset epilepsy syndrome. Its manifestations begin with seizures induced by fever or hyperthermia at six-nine months, which progress to spontaneous myoclonic, tonic-clonic, absence, and partial seizures (Dravet et al., 2005; Oguni et al., 2001) . During this period of frequent polymorphic seizures, children with DS develop several co-morbid conditions including psychomotor regression, ataxia, sleep disturbance, cognitive impairments, and many die prematurely (Dravet et al., 2005; Oguni et al., 2001) . DS is caused by loss-of-function mutations in one allele of the SCN1A gene encoding the Na V 1.1 sodium channel (Claes et al., 2003; Claes et al., 2001 ). Mouse models of DS develop its key phenotypic features including epilepsy with early (P21) onset, high susceptibility to hyperthermiainduced seizures, ataxia, spontaneous seizures, autistic-like behaviors, and premature death (Catterall et al., 2010; Han et al., 2012a; Kalume et al., 2013; Kalume et al., 2007; Oakley et al., 2009; Ogiwara et al., 2007; Yu et al., 2006) . Deletion of Na V 1.1 channels in DS mice preferentially reduces sodium current in inhibitory neurons in the hippocampus but not in excitatory neurons (Yu et al., 2006) , suggesting that selective loss of excitability of inhibitory neurons is responsible for hyperexcitability in DS. Reduced Na V current and excitability in cerebellar Purkinje neurons, which are GABAergic inhibitory neurons, may cause ataxia (Kalume et al., 2007) . These findings led to the unified hypothesis that reduced Na V current in GABAergic neurons in different brain regions may be responsible for the multiple, seemingly unrelated comorbidities of DS, such as sleep disturbance and cognitive impairment (Catterall et al., 2010; Yu et al., 2006) . In support of this hypothesis, Neurobiology of Disease 77 (2015) 141-154 
